Avalyn Pharma (AVLN) Stock Price & Analysis

AVLN$30.28-0.31 -1.01%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$1.35BEnterprise value$1.22BRevenue (TTM)$0Market position—

Score

71
Bullish
Value
64
Quality
50
Growth
100

AI Analysis

Snapshot

Avalyn Pharma Inc. Common Stock is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 71/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~98% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

64
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

50
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Avalyn Pharma Inc. Common Stock (AVLN) last printed $30.28. Equity value is $1.35B. Trailing earnings multiple —. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

20242025
$0.00$0.00

About

Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.

Avalyn Pharma (AVLN) Stock Price & Analysis

AVLN price $30.28 -0.31 -1.01%

Ticker
AVLN
Price
$30.28
Change
-0.31 -1.01%
Market cap
$1.35B
Dividend yield
0.00%
Beta
-1.13
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
71
Value
64
Quality
50
Growth
100

Stocklytics score rationale: value 64, quality 50, growth 100.

Fair value

AVLN fair value Not meaningful. Price $30.28.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 28.4, a blend of the industry median and the stock's own 10-year median. How we calculate it →

Not meaningful

Compare AVLN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-11—-0.74——
2026-11-12-0.67-0.67——
2026-08-12-0.98-0.78——
2026-06-03-21.83-5.98——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-11-10FMR LLCSell5.57K$29.56164.50K
2026-11-10FMR LLCSell47.89K$30.281.45M
2026-11-09FMR LLCSell173.66K$29.065.05M
2026-11-09FMR LLCSell1.34K$29.7539.84K
2026-09-15Meyer Robert J.Buy31.18K$34.281.07M
2026-09-15Meyer Robert J.Other0——

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 51, holders -44 vs prior quarter. Ownership 35.87%.

HolderSharesChangeChange %Value
FMR LLC6.19M350.74K+6.01%176.24M
NVP ASSOCIATES, LLC2.27M00.00%64.63M
EVENTIDE ASSET MANAGEMENT, LLC1.38M00.00%39.19M
BLACKROCK, INC.1.33M347.75K+35.58%37.75M
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC866.79K-100.00K-10.34%24.69M
VANGUARD CAPITAL MANAGEMENT LLC752.82K13.04K+1.76%21.45M
STATE STREET CORP554.00K235.01K+73.67%15.78M
GEODE CAPITAL MANAGEMENT, LLC471.06K36.41K+8.38%13.42M
SILVERARC CAPITAL MANAGEMENT, LLC378.35K47.87K+14.48%10.78M
FRANKLIN TEMPLETON INC331.68K00.00%9.11M
UBS GROUP AG189.25K189.25KNew5.39M
FEDERATED HERMES, INC.160.00K00.00%4.56M
JONES HILL CAPITAL LP126.74K126.74KNew3.61M
VANGUARD PORTFOLIO MANAGEMENT LLC125.80K8.47K+7.22%3.58M
VANGUARD FIDUCIARY TRUST CO122.93K6.17K+5.28%3.50M
MANUFACTURERS LIFE INSURANCE COMPANY, THE95.56K95.56KNew2.72M
TD ASSET MANAGEMENT INC98.18K3.55K+3.75%2.66M
WALLEYE CAPITAL LLC54.58K54.58KNew1.56M
QUADRATURE CAPITAL LTD47.47K47.47KNew1.35M
QUANTINNO CAPITAL MANAGEMENT LP47.12K47.12KNew1.34M
BANK OF NEW YORK MELLON CORP44.04K44.04KNew1.25M
MORGAN STANLEY32.25K32.25KNew918.69K
SWISS NATIONAL BANK31.40K31.40KNew894.59K
NUVEEN, LLC31.25K31.25KNew890.28K
PROFUND ADVISORS LLC23.43K23.43KNew667.61K

Insights · Forecast · Financials · Learn

Stocklytics home · Screener